European Parliament approves CSDDD in ‘major political breakthrough’
Michael Nelson reports on ‘a crucial step to holding companies accountable for their negative impacts’
Robots, drugs and fees: The key trends that have shaped ETFs
The last 10 years have seen ETF products grow from pre-teens to fully fledged adults, even dabbling with drugs along the way. 7IM’s passive expert and senior investment manager Peter Sleep looks back at the biggest trends.
